Daphne S. Bakker

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker et al. · Allergy · 2019 · 146 citations · Full text

Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers

Daphne S. Bakker, Stefan Nierkens, Edward F. Knol et al. · Journal of Allergy and Clinical Immunology · 2020 · 119 citations

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst et al. · Journal of the American Academy of Dermatology · 2020 · 88 citations · Full text

Atopic Dermatitis, Allergy Medicine, Outcomes Research +6

Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

Daphne S. Bakker, Marlot van der Wal, Lukas E. M. Heeb et al. · Journal of Investigative Dermatology · 2021 · 78 citations · Full text

Dupilumab facial redness: Positive effect of itraconazole

Fleur S.A. de Beer, Daphne S. Bakker, Inge Haeck et al. · JAAD Case Reports · 2019 · 56 citations · Full text

Inflammation, Dupilumab Facial Redness, Ophthalmology +12